Related Articles:

BMS-187257, a potent, selective, and novel heterocyclic β 3 adrenergic receptor agonist

[Fisher, Liesl G.; Sher, Philip M.; Skwish, Stephen; Michel, Inge M.; Seiler, Steven M.; Dickinson, Kenneth E. J. Bioorganic and Medicinal Chemistry Letters, 1996 , vol. 6, # 19 p. 2253 - 2258]

3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes

[Bioorganic and Medicinal Chemistry Letters, , vol. 17, # 5 p. 1274 - 1279]

Probing the Helical Secondary Structure of Short??Chain β??Peptides

[Seebach, Dieter; Ciceri, Paola E.; Overhand, Mark; Jaun, Bernhard; Rigo, Dario; Oberer, Lukas; Hommel, Ulrich; Amstutz, Rene; Widmer, Hans Helvetica Chimica Acta, 1996 , vol. 79, # 8 p. 2043 - 2066]

3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes

[Bioorganic and Medicinal Chemistry Letters, , vol. 17, # 5 p. 1274 - 1279]